Fisetin Induces Apoptosis and Inhibits Migration of Melanoma Cells by Suppressing Glycolytic Metabolism via PKM2 Inhibition
Open Access
- 1 January 2026
- journal article
- Published by XMLink in Annals of Dermatology
- Vol. 38 (5) , 451
Abstract
No abstract availableFunding Information
- Soonchunhyang University
This publication has 10 references indexed in Scilit:
- Altered metabolism in cancer: insights into energy pathways and therapeutic targetsMolecular Cancer, 2024
- Determinants of resistance and response to melanoma therapyNature Cancer, 2024
- Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted deliveryJournal of Experimental & Clinical Cancer Research, 2023
- Metabolic reprogramming in cancer: Mechanisms and therapeuticsMedcomm, 2023
- BRAF activation by metabolic stress promotes glycolysis sensitizing NRASQ61-mutated melanomas to targeted therapyNature Communications, 2022
- Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor CellsInternational Journal of Molecular Sciences, 2022
- Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signalingMolecular Cancer, 2018
- Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growthCancer Cell International, 2016
- PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinomaOncotarget, 2014
- Fisetin: A Dietary Antioxidant for Health PromotionAntioxidants & Redox Signaling, 2013